Innocenzo Rainero, MD, PhD, is an Italian medical scientist, neurologist and molecular geneticist. Member of the Familial Alzheimer’s disease Research Group that identified key genes of early-onset Alzheimer's disease (AD), including the presenilin 1 gene, the most common cause of familial AD, and SORL1 gene. He leaded the group that showed mutations in the SQSTM1 gene in Frontotemporal dementia. In addition, he is involved in molecular genetics of migraine and cluster headache. He completed his medical training in Torino (Italy), graduating with the MD degree with honors in 1982, and then pursuing post-doctoral research in Neurology at the University of Torino. From 1986 to 1987, Visiting Scientist at the National Institute on Aging (N.I.H., Bethesda, USA) and then Fellow of the French Foundation for Alzheimer’s disease (Los Angeles, CA, USA) (1989-1991). In 2005, was appointed to the University of Torino as Associate Professor of Neurology, and has held the university's highest rank of University Professor. Involved in several non-profit and profit clinical trials of new drugs for AD and migraine. Member of the National Board of the Italian Neurological Society for the Study of Dementia (SINdem) and the National Board of the Italian Society for the Study of Headache (SISC).